Title:
The nucleic-acid vaccine which receives simple-herpes-virus 2 type: A constituent and a method of inducing an immune response
Document Type and Number:
Japanese Patent JP6199878
Kind Code:
B2
Abstract:
Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. Highly effective vaccines and immunogenic compositions against HSV-2 which can be used therapeutically or prophylactically, are described.
Inventors:
Long, deborah
Flexner, jessica
Scoburn, Moika
Flexner, jessica
Scoburn, Moika
Application Number:
JP2014543554A
Publication Date:
September 20, 2017
Filing Date:
November 21, 2012
Export Citation:
Assignee:
Genocair Biosciences, Inc.
International Classes:
A61K39/245; A61K38/20; A61K39/39; A61K48/00; A61P31/22
Other References:
J. Immuno.,2000年,164,5167-76
Vaccine,2011年 1月,29,2071-8
PNAS,1996年,93,11414-20
Virology,2000年,269,47-53
DNA,1984年,3(1),23-9
Vaccine,2011年 1月,29,2071-8
PNAS,1996年,93,11414-20
Virology,2000年,269,47-53
DNA,1984年,3(1),23-9
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Previous Patent: Medicine vaporization object
Next Patent: ALPHA-PHOSPHONOSULPHONATE SQUALENE SYNTHETASE INHIBITOR
Next Patent: ALPHA-PHOSPHONOSULPHONATE SQUALENE SYNTHETASE INHIBITOR